Table 1.
Baseline characteristics by cohort
| Participants, n (%) | |||
|---|---|---|---|
| De Novo | Rollover | All participants | |
| (N=395) | (N=87) | (N=482) | |
| Sex | |||
| Male | 266 (67.3) | 60 (69.0) | 326 (67.6) |
| Female | 129 (32.7) | 27 (31.0) | 156 (32.4) |
| Age, years | |||
| ≤20 | 2 (0.5) | 1 (1.1) | 3 (0.6) |
| 21–30 | 38 (9.6) | 10 (11.5) | 48 (10.0) |
| 31–40 | 78 (19.7) | 24 (27.6) | 102 (21.2) |
| 41–50 | 124 (31.4) | 32 (36.8) | 156 (32.4) |
| 51–55 | 83 (21.0) | 19 (21.8) | 102 (21.2) |
| 56–65 | 70 (17.7) | 1 (1.1) | 71 (14.7) |
| Race | |||
| Caucasian | 105 (26.6) | 25 (28.7) | 130 (27.0) |
| African American | 283 (71.6) | 59 (67.8) | 342 (71.0) |
| Asian | 3 (0.8) | 1 (1.1) | 4 (0.8) |
| American Indian or Alaska Native | 2 (0.5) | 0 | 2 (0.4) |
| Native Hawaiian or Other Pacific Islander | 1 (0.3) | 2 (2.3) | 3 (0.6) |
| Other | 1 (0.3) | 0 | 1 (0.2) |
Abbreviations: EOS, end of study; SWN-S, subjective well-being under neuroleptic scale.